Journal of Pharmaceutical Sciences

Papers
(The H4-Index of Journal of Pharmaceutical Sciences is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Addressing the Cold Reality of mRNA Vaccine Stability293
A review of Formulations of Commercially Available Antibodies110
Manufacturing Challenges and Rational Formulation Development for AAV Viral Vectors104
Delivery of Therapeutics from Layer-by-Layer Electrospun Nanofiber Matrix for Wound Healing: An Update81
Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release73
A Graphical Review on the Escalation of Fused Deposition Modeling (FDM) 3D Printing in the Pharmaceutical Field58
Sodium Alginate as a Pharmaceutical Excipient: Novel Applications of a Well-known Polymer57
The Ice-Water Interface and Protein Stability: A Review56
Implementation of a Human Renal Proximal Tubule on a Chip for Nephrotoxicity and Drug Interaction Studies55
Fabrication of Mucoadhesive Buccal Films for Local Administration of Ketoprofen and Lidocaine Hydrochloride by Combining Fused Deposition Modeling and Inkjet Printing50
Rapid Polysorbate 80 Degradation by Liver Carboxylesterase in a Monoclonal Antibody Formulated Drug Substance at Early Stage Development49
Nitrosamine Contamination in Pharmaceuticals: Threat, Impact, and Control49
3D Printing of Solid Oral Dosage Forms: Numerous Challenges With Unique Opportunities49
Binder-Jet 3D Printing of Indomethacin-laden Pharmaceutical Dosage Forms49
Predicting With Confidence: Using Conformal Prediction in Drug Discovery48
Application of Deep Learning Convolutional Neural Networks for Internal Tablet Defect Detection: High Accuracy, Throughput, and Adaptability48
The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption Studies48
Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule47
Cyclodextrins in Parenteral Formulations46
Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy46
Selective Laser Sintering 3-Dimensional Printing as a Single Step Process to Prepare Amorphous Solid Dispersion Dosage Forms for Improved Solubility and Dissolution Rate41
Intradermal Implantable PLGA Microneedles for Etonogestrel Sustained Release40
The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines40
Freeze-Drying of Pharmaceutical and Nutraceutical Nanoparticles: The Effects of Formulation and Technique Parameters on Nanoparticles Characteristics40
Three-Dimensional Spheroids With Primary Human Liver Cells and Differential Roles of Kupffer Cells in Drug-Induced Liver Injury39
The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case38
Engineering Stability, Viscosity, and Immunogenicity of Antibodies by Computational Design37
Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing37
Capsaicin Loaded Solid SNEDDS for Enhanced Bioavailability and Anticancer Activity: In-Vitro, In-Silico, and In-Vivo Characterization37
How can Electrospinning Further Service Well for Pharmaceutical Researches?36
Boric Acid, a Lewis Acid With Unique and Unusual Properties: Formulation Implications36
Comprehensive Size Distribution and Composition Analysis of Adeno-Associated Virus Vector by Multiwavelength Sedimentation Velocity Analytical Ultracentrifugation34
Novel Chitosan-Coated Niosomal Formulation for Improved Management of Bacterial Conjunctivitis: A Highly Permeable and Efficient Ocular Nanocarrier for Azithromycin34
Preparation and Characterization of Docetaxel-PLGA Nanoparticles Coated with Folic Acid-chitosan Conjugate for Cancer Treatment34
Perspectives About Self-Immolative Drug Delivery Systems34
0.043478012084961